Investment in Jubilant HollisterStier will strengthen Canada's biomanufacturing capacity for vaccine and therapeutics production to protect Canadians against future health threats
The Government of Canada continues to make significant investments to strengthen Canada's biomanufacturing and life sciences sector. Our approach prioritizes innovative solutions and long-term domestic biomanufacturing capacity right here at home. Since March 2020, over $1.8 billion has been invested across 34 projects to rebuild Canada's vaccines, therapeutics and biomanufacturing capacity.
Today, the Honourable Pablo Rodriguez, Minister of Canadian Heritage and Quebec Lieutenant, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a contribution of $23.8 million to support Jubilant HollisterStier's $108.3 million project through the Strategic Innovation Fund. This contribution will increase Jubilant HollisterStier's capacity for a variety of vaccines, including mRNA. This will boost Canada's domestic capabilities and help ensure that we are well positioned to protect the health and safety of Canadians for years to come.
This project aligns with Canada's Biomanufacturing and Life Sciences Strategy and will substantially increase Jubilant HollisterStier's annual fill and finish capacity once completed. This investment supports the growth of Canada's life sciences ecosystem, while driving innovation. With this contribution, Jubilant HollisterStier will create and maintain 311 good, well-paying jobs, here in Quebec.
